In the present study, we found that there was indeed heterogeneity in the expression level, the correlation with oncogenes or tumor suppressor genes of LEPROT across cancer types, but at the same time, we were surprised to notice the remarkably consistent correlation of LEPROT and effector T cells, resident memory T cells, Th1 cells, and CAFs across all cancer types. The gene discussed is LEPROT; the disease is cancer.